CONTINUE TO SITE

OR WAIT null SECS

COVID-19 Update Analytics Development Downstream Processing Manufacturing Outsourcing Quality/GMPs Upstream Processing

COVID-19 UpdateAnalyticsDevelopmentDownstream ProcessingManufacturingOutsourcingQuality/GMPsUpstream Processing

View More Analytical Methods BioBusiness Cell Culture/Fermentation Continuous Processing Drug Delivery Fill/Finish Formulation Process Chromatography Process Control/PAT Process Development QA/QC Separation and Purification Single-Use Systems Supply Chain

Analytical MethodsBioBusinessCell Culture/FermentationContinuous ProcessingDrug DeliveryFill/FinishFormulationProcess ChromatographyProcess Control/PATProcess DevelopmentQA/QCSeparation and PurificationSingle-Use SystemsSupply Chain

News

All News Top News Bio/Pharma News Industry News Supplier News Events

All NewsTop NewsBio/Pharma NewsIndustry NewsSupplier NewsEvents

Publications

All Publications BioPharm International

All PublicationsBioPharm International

Resources

Biopharma Insights Sponsored eBooks Sponsored Podcasts Sponsored Videos Whitepapers

Biopharma InsightsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers

Webcasts

Enews Magazine

EnewsMagazine

About Us
Advertise
Editorial Information
Contact Us
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Spotlight

COVID-19 Update
Analytics
Development
Downstream Processing
Manufacturing
Outsourcing
Quality/GMPs
Upstream Processing

TopicSee All >

Analytical Methods
BioBusiness
Cell Culture/Fermentation
Continuous Processing
Drug Delivery
Fill/Finish
Formulation
Process Chromatography
Process Control/PAT
Process Development
QA/QC
Separation and Purification
Single-Use Systems
Supply Chain

About Us
Advertise
Editorial Information
Contact Us
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

BioTrends: M&A Malaise

June 15, 2003

Desiree de Myer

BioPharm International, BioPharm International-06-01-2003, Volume 16, Issue 6

by Desiree de Myer, BioPharm International Despite market conditions favorable to merger and acquisition activity, a frenzy of consolidations still hasn't taken place.

Related Content:

Guest Interview: A Strong Dose of Reality: Visiting with Cynthia Robbins-Roth

Collaborating Across the Extended Pharmaceutical Enterprise: How Sharing Information Leads to Process Enablement

Sialylation Levels Influence Oligosaccharide Quantitation: Analyzing Response Variability Using High-pH Anion-Exchange Chromatography and Pulsed Amperometric Detection